Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl Into Schedule I
scheduling · Proposed Rule · Notice of proposed rulemaking. · Published 2018-05-10 · 83 FR 21826
Document
Document number
2018-10008
Federal Register citation
83 FR 21826
Type
Proposed Rule
Action
Notice of proposed rulemaking.
Category
scheduling
Publication date
2018-05-10
Abstract
The Drug Enforcement Administration proposes placing beta- hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin- 4-yl]-N-phenylpropionamide) also known as N-[1-[2-hydroxy-2-(2- thienyl)ethyl]4-piperidinyl]N-phenyl-propanamide including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle beta-hydroxythiofentanyl.